Botschuijver, Sara
van Diest, Sophie A.
van Thiel, Isabelle A. M. http://orcid.org/0000-0002-8298-9048
Saia, Rafael S.
Strik, Anne S.
Yu, Zhumei
Maria-Ferreira, Daniele http://orcid.org/0000-0001-7992-510X
Welting, Olaf
Keszthelyi, Daniel
Jennings, Gary
Heinsbroek, Sigrid E. M.
Elferink, Ronald P. Oude http://orcid.org/0000-0002-1779-0833
Schuren, Frank H. J. http://orcid.org/0000-0001-6982-5340
de Jonge, Wouter J.
van den Wijngaard, René M.
Article History
Received: 28 February 2019
Accepted: 2 August 2019
First Online: 29 August 2019
Competing Interests
: W.J.D.J., received consultancy fees from GlaxoSmithKline and research support from Galvani Bioelectronics, GlaxoSmithKline and Mead Johnsson Nutrition Pediatric Institute. Although G.J. used to be employed by JADO Technologies GmbH, there is no competing interest as the interest (JADO) no longer exists and no successor interests exist either (the discovery of anti-inflammatory effects of miltefosine in mastocytosis, atopic dermatitis and urticaria are in the public domain). All other authors declare no financial competing interests. All authors declare no non-financial competing interests.